Apptomics Inc

Chronic neurological conditions affect 450+ million people globally, representing more than 75% of all healthcare costs. Current models for disease management require neurologists to rely on patient-reported symptomatic information and in-clinic assessments. The lack of precise information results in missed opportunities for proactive therapy refinement and the potential for suboptimal outcomes. Recognizing the need for new mHealth technologies that bridge the gap in health care, Apptomics is revolutionizing the way patients and physicians manage chronic neurological conditions by capturing more accurate insights into disease progression. The company’s patent-pending digital solution provides continuous remote health monitoring and secure exchange of both objective and self-reported data collected both during and in between office visits. Neurologists now have access to reliable and rich datasets that can help inform faster interventions, provide more personalized treatment regimens, and reduce overall costs.